15 September 2022: Clinical Research
Endobiliary Ablation Combined with Immune Nutrition Improves Quality of Life: A Preliminary Clinical Study in Patients with Advanced Malignant Obstructive Jaundice
Jie Yao 1ABE , Yalin Kong 2A* , Cheng Wang 2C , Yaping Wei 1BD , Hailian Li 1DE , Chengli Liu 23DEF*DOI: 10.12659/MSM.936863
Med Sci Monit 2022; 28:e936863
Table 4 Secondary outcomes of the studied groups.
| Variable | Study group (n=31) | Control group (n=28) | P value |
|---|---|---|---|
| 11.3±4.7 | 12.6±4.2 | 0.268 | |
| 7.7±3.1 | 7.5±2.8 | 0.562 | |
| CRP (mg/L) | 15.2±6.2 | 38.6±11.4 | 0.027* |
| IL-1 (pg/ml) | 64.3±12.4 | 103.6±18.6 | 0.016* |
| IL-6 (pg/ml) | 132.4±43.7 | 288.6±33.6 | * |
| TNF-α (pg/mL) | 1638±76.4 | 2168±87.8 | 0.036* |
| 14 (45.2%) | 12 (42.9%) | 0.550 | |
| Infection | 7 (22.6%) | 6 (21.4%) | 0.589 |
| Biliary bleeding | 5 (16.1%) | 4 (14.3%) | 0.577 |
| Acute pancreatitis | 1 (3.2%) | 2 (7.1%) | 0.607 |
| Moderate pain | 6 (19.4%) | 4 (14.3%) | 0.742 |
| * | |||